In the US, Tazicef (ceftazidime systemic) is a member of the drug class third generation cephalosporins and is used to treat Bacteremia, Bladder Infection, Bone infection, Endocarditis, Endometritis, Febrile Neutropenia, Intraabdominal Infection, Joint Infection, Kidney Infections, Melioidosis, Meningitis, Nosocomial Pneumonia, Otitis Externa, Otitis Media, Pelvic Inflammatory Disease, Peritonitis, Pneumonia, Pneumonia with Cystic Fibrosis, Sepsis, Septicemia, Sinusitis, Skin and Structure Infection, Skin or Soft Tissue Infection and Urinary Tract Infection.
Ingredient matches for Tazicef
Ceftazidime is reported as an ingredient of Tazicef in the following countries:
- South Korea
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.